Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

156.27 +17.38 (+12.51%)

Streaming Delayed Price Updated: 2:10 PM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stocks Fall, S&P 500 Eyes Worst Month In Almost Two Years, Oil Rallies: What's Driving Markets Monday? ↗

March 31, 2025

Risk sentiment remains under pressure at the start of the week on Wall Street, with tech-heavy indexes sliding while commodities advance, as traders fear a new wave of price pressures following the...

Via Benzinga

Topics Stocks World Trade

Nasdaq Continues Selloff, Eyes Worst Month Since 2022 ↗

March 31, 2025

All three major indexes are on track for monthly and quarterly losses.

Via Talk Markets

Topics Stocks / Equities

What's going on in today's session: S&P500 gap up and gap down stocks ↗

March 31, 2025

Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks that are showing activity before the opening bell on Monday. ↗

March 31, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Moderna, Novavax Shares Are Tumbling Monday: What's Going On? ↗

March 31, 2025

Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration.

Via Benzinga

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns ↗

March 31, 2025

Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies.

Via Investor's Business Daily

Peering Into Moderna's Recent Short Interest ↗

March 31, 2025

Via Benzinga

Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults

March 31, 2025

Via ACCESS Newswire

10 Worst Performing Large-Caps Last 12 Months ↗

March 27, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

What's going on in today's session: S&P500 movers ↗

March 26, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On? ↗

March 26, 2025

Vaccine makers Moderna Inc (NASDAQ:MRNA) and Novavax Inc (NASDAQ:NVAX) are facing selling pressure on Wednesday following reports suggesting the Trump administration will end support for Gavi.

Via Benzinga

Topics Government

Which S&P500 stocks are gapping on Wednesday? ↗

March 26, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends.

Via Chartmill

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

March 24, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst...

Via StockStory

Topics Artificial Intelligence

XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio? ↗

March 23, 2025

Large-cap stocks worst performers last week, including BEKE, RDDT, FUTU, JHX, INCY, NUE, BAH, XPEV, MRNA, TU, WLK. Are they in your portfolio?

Via Benzinga

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move ↗

March 22, 2025

Via The Motley Fool

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

March 21, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its...

Via StockStory

Topics Artificial Intelligence

4 Things You Need to Know if You Buy Moderna Stock Today ↗

March 20, 2025

Via The Motley Fool

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

March 20, 2025

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

2 No-Brainer Biotech Stocks to Buy Right Now ↗

March 19, 2025

Via The Motley Fool

Which S&P500 stocks are gapping on Wednesday? ↗

March 19, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

March 19, 2025

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

MarketBeat Week in Review – 03/10 - 03/14

March 15, 2025

Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunities

Via MarketBeat

Topics Economy World Trade

Down 93%, Is It Finally Time to Buy Moderna? ↗

March 15, 2025

Via The Motley Fool

10 Worst Performing Large-Caps Last 12 Months ↗

March 13, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) ↗

March 13, 2025

Via Benzinga

3 Reasons MRNA is Risky and 1 Stock to Buy Instead

March 12, 2025

Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per share. This was partly due to its softer quarterly results and might have...

Via StockStory

Top S&P500 movers in Tuesday's session ↗

March 11, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

March 11, 2025

Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Gapping S&P500 stocks in Tuesday's session ↗

March 11, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

March 11, 2025

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

Via MarketBeat

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.